T1	Participants 164 201	Medical Research Council ASTEC Trial.
T2	Participants 359 407	these women are more likely to be older or obese
T3	Participants 288 310	endometrial malignancy
T4	Participants 698 742	Women with presumed early endometrial cancer
T5	Participants 106 145	Presumed Early-Stage Endometrial Cancer
T6	Participants 1008 1018	1408 women
